文献速递冠心病

院前和肽素联合院内肌钙蛋白加速排除急性心肌梗死:AROMI研究

Accelerated -Rule-Out of acute Myocardial Infarction using prehospital copeptin and in-hospital troponin: The AROMI study.
PubMed 文献 · Eur Heart J · 2023-01-01

AROMI研究将4351例疑似AMI患者随机分为加速双标志物排除组(院前和肽素+院内hs-cTnT)与标准0h/3h排除组。加速策略使排除后出院患者平均住院时间缩短0.9小时,30天MACE非劣效(绝对风险差-0.4%,95%CI -2.5至1.7;非劣效P=0.013)。

要点

  • 院前和肽素联合入院hs-cTnT可加速排除AMI并缩短住院时间。
  • 加速策略30天MACE非劣效于标准0h/3h排除策略。
  • 适用于救护车转运的疑似AMI患者。

核心结论

  • 加速双标志物排除策略(院前和肽素+入院首次hs-cTnT)相比0h/3h策略缩短住院时间且不增加30天MACE。

研究设计与样本

  • 随机对照试验,4351例疑似AMI且由救护车转运至医院的患者,1:1随机分为加速双标志物排除组与标准0h/3h排除组。

主要发现

  • 在排除AMI后出院患者中,加速策略平均缩短住院时间0.9小时(95%CI 0.7-1.1)。
  • 30天MACE绝对风险差-0.4%(95%CI -2.5至1.7),非劣效P=0.013。

临床怎么用

  • 对救护车转运的疑似AMI患者,可采用院前和肽素联合入院hs-cTnT加速排除AMI以缩短住院时间。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: The present acute myocardial infarction (AMI) rule-out strategies are challenged by the late temporal release of cardiac troponin. Copeptin is a non-specific biomarker of endogenous stress and rises early in AMI, covering the early period where troponin is still normal. An accelerated dual-marker rule-out strategy combining prehospital copeptin and in-hospital high-sensitivity troponin T could reduce length of hospital stay and thus the burden on the health care systems worldwide. The AROMI trial aimed to evaluate if the accelerated dual-marker rule-out strategy could safely reduce length of stay in patients discharged after early rule-out of AMI. METHODS AND RESULTS: Patients with suspected AMI transported to hospital by ambulance were randomized 1:1 to either accelerated rule-out using copeptin measured in a prehospital blood sample and high-sensitivity troponin T measured at arrival to hospital or to standard rule-out using a 0 h/3 h rule-out strategy. The AROMI study included 4351 patients with suspected AMI. The accelerated dual-marker rule-out strategy reduced mean length of stay by 0.9 h (95% confidence interval 0.7-1.1 h) in patients discharged after rule-out of AMI and was non-inferior regarding 30-day major adverse cardiac events when compared to standard rule-out (absolute risk difference -0.4%, 95% confidence interval -2.5 to 1.7; P-value for non-inferiority = 0.013). CONCLUSION: Accelerated dual marker rule-out of AMI, using a combination of prehospital copeptin and first in-hospital high-sensitivity troponin T, reduces length of hospital stay without increasing the rate of 30-day major adverse cardiac events as compared to using a 0 h/3 h rule-out strategy.

来源:Eur Heart J,查看原文。版权归原作者所有。

引用

  1. Pedersen, Stengaard, Bøtker, et al. Accelerated -Rule-Out of acute Myocardial Infarction using prehospital copeptin and in-hospital troponin: The AROMI study. Eur Heart J. 2023. PMID: 37477353. doi:10.1093/eurheartj/ehad447

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。